Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» SPK-8011
SPK-8011
What's Next for Spark Therapeutics
What's Next for Spark Therapeutics
Motley Fool
Spark Therapeutics
hemophilia
SPK-8011
Flag link:
3 Biotech Stocks With Major Catalysts Incoming
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Spark Therapeutics
Zogenix
Progenics Pharmaceuticals
SPK-8011
ZX008
Azedra
FDA
Flag link:
ASH17: Spark gene therapy falls behind BioMarin in hemophilia
ASH17: Spark gene therapy falls behind BioMarin in hemophilia
BioPharma Dive
ASH17
Spark Therapeutics
gene therapy
Biomarin
hemophilia A
SPK-8011
Flag link:
9 Notable Biotechs Presenting At This Year's ASH Meeting
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Flag link:
Spark offers a glimpse of efficacy in first two hemophilia A gene therapy patients
Spark offers a glimpse of efficacy in first two hemophilia A gene therapy patients
Endpoints
Spark Therapeutics
hemophilia A
gene therapy
SPK-8011
Flag link:
